Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chytil

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2003
HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activityK Ulbrich, T Etrych, P Chytil, et al.
Journal of Drug Targeting|October 8, 2011
Novel star HPMA-based polymer conjugates for passive targeting to solid tumorsT Etrych, J Strohalm, P Chytil, et al.
Journal of Drug Targeting|December 29, 2004
Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activationK Ulbrich, T Etrych, P Chytil, et al.
Physiological Research|October 9, 2015
Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samplesE Koziolova, O Janouskova, P Chytil, et al.
International Journal of Pharmaceutics|May 26, 2004
Polymeric anticancer drugs with pH-controlled activationK Ulbrich, T Etrych, P Chytil, et al.
Physiological Research|October 9, 2015
The comparison of in vivo properties of water-soluble HPMA-based polymer conjugates with doxorubicin prepared by controlled RAFT or free radical polymerizationP Chytil, M Šírová, E Koziolová, et al.
Physiological Research|October 9, 2015
Nanotherapeutics shielded with a pH responsive polymeric layerL Kostka, V Šubr, R Laga, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2008
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targetingP Chytil, T Etrych, C Konák, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Journal of Materials Chemistry. B|April 9, 2020
Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulationE Koziolová, D Machová, R Pola, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 6, 2003
HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activityK Ulbrich, T Etrych, P Chytil, et al.
Journal of Drug Targeting|October 8, 2011
Novel star HPMA-based polymer conjugates for passive targeting to solid tumorsT Etrych, J Strohalm, P Chytil, et al.
Journal of Drug Targeting|December 29, 2004
Antibody-targeted polymer-doxorubicin conjugates with pH-controlled activationK Ulbrich, T Etrych, P Chytil, et al.
Physiological Research|October 9, 2015
Nanotherapeutics with anthracyclines: methods of determination and quantification of anthracyclines in biological samplesE Koziolova, O Janouskova, P Chytil, et al.
International Journal of Pharmaceutics|May 26, 2004
Polymeric anticancer drugs with pH-controlled activationK Ulbrich, T Etrych, P Chytil, et al.
Physiological Research|October 9, 2015
The comparison of in vivo properties of water-soluble HPMA-based polymer conjugates with doxorubicin prepared by controlled RAFT or free radical polymerizationP Chytil, M Šírová, E Koziolová, et al.
Physiological Research|October 9, 2015
Nanotherapeutics shielded with a pH responsive polymeric layerL Kostka, V Šubr, R Laga, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2008
New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targetingP Chytil, T Etrych, C Konák, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 8, 2008
Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequencesB Ríhová, J Strohalm, O Hovorka, et al.
Journal of Materials Chemistry. B|April 9, 2020
Micelle-forming HPMA copolymer conjugates of ritonavir bound via a pH-sensitive spacer with improved cellular uptake designed for enhanced tumor accumulationE Koziolová, D Machová, R Pola, et al.
Pageof 2